APA

Pietrzyk J. J., Wysocki J., Pejcz J., Galaj A., Majda-Stanislawska E., Käyhty H., Thierry-Carstensen B. & Jensen A. M. (20081223). Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. : Vaccine.

Chicago

Pietrzyk Jacek J, Wysocki Jacek, Pejcz Jerzy, Galaj Andrzej, Majda-Stanislawska Ewa, Käyhty Helena, Thierry-Carstensen Birgit and Jensen Anders Mørup. 20081223. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. : Vaccine.

Harvard

Pietrzyk J. J., Wysocki J., Pejcz J., Galaj A., Majda-Stanislawska E., Käyhty H., Thierry-Carstensen B. and Jensen A. M. (20081223). Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. : Vaccine.

MLA

Pietrzyk Jacek J, Wysocki Jacek, Pejcz Jerzy, Galaj Andrzej, Majda-Stanislawska Ewa, Käyhty Helena, Thierry-Carstensen Birgit and Jensen Anders Mørup. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. : Vaccine. 20081223.